Inventor
Hawkins Rebecca
US15 patents
⚠️ This page may combine multiple inventors who share the name “Hawkins Rebecca”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN BIOTECH INC
9 patentsUS10626165B2Apr 21, 2020
CD8a-binding fibronectin type III domains
JANSSEN BIOTECH INC14 citations93
US10611823B2Apr 7, 2020
CD137 binding fibronectin type III domains
JANSSEN BIOTECH INC12 citations85
US10597438B2Mar 24, 2020
PD-L1 binding fibronectin type III domains
JANSSEN BIOTECH INC12 citations85
US11299534B2Apr 12, 2022
CD8A-binding fibronectin type III domains
JANSSEN BIOTECH INC4 citations83
US11932680B2Mar 19, 2024
CD8A-binding fibronectin type III domains
JANSSEN BIOTECH INC2 citations72
US11345739B2May 31, 2022
CD137 binding fibronectin type III domains
JANSSEN BIOTECH INC1 citations72
US12559541B2Feb 24, 2026
CD8A-binding fibronectin type III domains
JANSSEN BIOTECH INC0 citations62
US12258385B2Mar 25, 2025
CD137 binding fibronectin type III domains
JANSSEN BIOTECH INC0 citations62
US11447539B2Sep 20, 2022
PD-L1 binding fibronectin type III domains
JANSSEN BIOTECH INC0 citations62
JANSSEN PHARMACEUTICA NV
6 patentsUS11207311B2Dec 28, 2021
Method of treating prostate cancer
JANSSEN PHARMACEUTICA NV6 citations82
US12383543B2Aug 12, 2025
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11992486B2May 28, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11986468B2May 21, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11986469B2May 21, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61
US11986470B2May 21, 2024
Methods of treating prostate cancer
JANSSEN PHARMACEUTICA NV0 citations61